Don Huffman has experience in merger and acquisition of biology and medical companies. CFO of 4 public companies. Three listed on NASDAQ and one OTC. Served on the board of SteadyMed Ltd. Which was purchased for 4.46 per share and a additional 2.63 a share with achievement milestone.
Possibly the best choice for shareholders.